[Form 4] Workday, Inc. Insider Trading Activity
Rhea-AI Filing Summary
David A. Duffield, a director of Workday, Inc. (WDAY), reported multiple transactions on 10/01/2025 in which he and related trusts/foundation sold Class A common stock and converted Class B shares. The Form 4 shows a 10/01/2025 purchase of 72,696 shares of Class A at $0 (conversion of Class B to Class A) and a series of sales totaling ~64,095 Class A shares executed under a Rule 10b5-1 plan at weighted average prices ranging from about $231.33 up to $242.44 across multiple tranches. Following these transactions the reporting person beneficially owned 41,621,988 Class A shares (direct) and retains 15,000 shares indirectly via the Dave and Cheryl Duffield Foundation.
The sales were executed by the David A. Duffield Trust, the Cheryl D. Duffield Trust, and the Dave & Cheryl Duffield Foundation under a trading plan adopted 12/03/2024. The Form 4 is signed by an attorney-in-fact on 10/03/2025.
Positive
- Retained substantial ownership: remains a direct beneficial owner of 41,621,988 Class A shares
- Used a Rule 10b5-1 plan: sales were executed under a trading plan adopted on 12/03/2024, indicating pre-planned transactions
Negative
- Significant share sales: sold approximately 64,095 Class A shares across multiple tranches on 10/01/2025
- Multiple sale price bands: sales executed at weighted average prices ranging from ~$231.33 to ~$242.44, indicating distribution of selling across price levels
Insights
Insider sold tens of thousands of shares via a pre-established 10b5-1 plan; large residual ownership remains.
The Form 4 discloses the sell-off of approximately 64,095 Class A shares on 10/01/2025 executed under a Rule 10b5-1 plan adopted 12/03/2024. Such plans permit scheduled sales and provide an affirmative defense to insider trading claims when properly adopted and followed.
Despite the sales, the reporting person still beneficially owns 41,621,988 Class A shares directly and an additional 15,000 shares indirectly via the Foundation, indicating ongoing substantial alignment with shareholders.
Sales occurred across price bands from about $231 to $242 per share; proceeds are material at market prices.
The filing lists weighted average prices and ranges for multiple sale tranches: low end ~$231.33 to high end ~$242.44. These represent executed liquidity events at those price bands on 10/01/2025.
The filing does not state total dollar proceeds or motives; it documents execution details and remaining share counts only.